Sort
21,281 grants matching “influenza”
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,110,860Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2022 · AI
Small molecule inhibitory leads against influenza RdRp
$1,108,397Thomas Roy Webb · St. Jude Children'S Research Hospital · R01 · FY2012 · AI
Crossprotective CTL Against Influenza
$1,108,246Ellis L Reinherz · Dana-Farber Cancer Inst · U01 · FY2013 · AI
Core_plus Option_B_C_Influenza Vaccine Effectiveness in a Wisconsin Population
$1,107,551Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2015 · IP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH
$1,107,422John Jay Treanor · University Of Rochester · N01 · FY2019 · AI
Rapid, single-dose coronavirus vaccines via DNA-launched nanoparticles and genetic adjuvants for durable anti-coronavirus immunity
$1,107,120David B. Weiner · Wistar Institute · P01 · FY2022 · AI
Novel Therapeutic Strategies Targeting Re-emerging Alphaviruses
$1,106,083Daniel N Streblow · University Of Alabama At Birmingham · U19 · FY2014 · AI
Seasonal Influenza Vaccine Effectiveness in a Tropical Developing African Country
$1,105,929John Christian Victor · Path · U01 · FY2008 · IP
Immunobiology and Virology of Influenza A Virus
$1,105,451Jonathan W Yewdell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Manipulating Epitope Immunodominance and Tracking B-cell-Antigen Interactions for Vaccine Design.
$1,105,200Amelia Escolano · Wistar Institute · DP2 · FY2025 · AI
Creating high-resolution, epitope-focused vaccines
$1,103,900Peter S Kim · Stanford University · DP1 · FY2020 · AI
Development of a Broad-Spectrum Inhibitor against Seasonal and Highly-Pathogenic Influenza Viruses
$1,103,435Richard K. Plemper · Georgia State University · R01 · FY2019 · AI
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,103,251Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2012 · AI
Clinical Core
$1,102,031Cornelia L Dekker · Stanford University · U19 · FY2016 · AI
Creating high-resolution, epitope-focused vaccines
$1,101,975Peter S Kim · Stanford University · DP1 · FY2021 · AI
Stopping URIs and FLU in the Family: the Stuffy Trial
$1,101,931Elaine Lucille Larson · Columbia University Health Sciences · U01 · FY2006 · CI
Creating high-resolution, epitope-focused vaccines
$1,101,800Peter S Kim · Stanford University · DP1 · FY2024 · AI
Creating high-resolution, epitope-focused vaccines
$1,101,800Peter S Kim · Stanford University · DP1 · FY2023 · AI
Oklahoma Center for Respiratory and Infectious Diseases
$1,101,147Lin Liu · Oklahoma State University Stillwater · P30 · FY2023 · GM
A Novel Live Non-replicating Universal Vaccine for Influenza
$1,101,041Sally R. Sarawar · Biomedical Research Instit/ Southern, Ca · R01 · FY2016 · AI
Reducing Transmission of Influenza by Face Masks
$1,101,016Arnold S Monto · University Of Michigan At Ann Arbor · U01 · FY2006 · CI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$1,100,000Stephan Bour · Digital Infuzion, Inc. · N01 · FY2024 · AI
CAREER: Mechanism of Protein Catalyzed Membrane Fusion
$1,100,000Justin Lorieau · University Of Illinois At Chicago · · FY2017 · BIO
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population
$1,100,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2016 · IP
Estimates of Influenza Vaccine Effectiveness
$1,100,000John Jay Treanor · University Of Rochester · U18 · FY2010 · IP